New Ways To Stave Off A.I.D.S.? (Press, 1 May 1986)

Research has emerged suggesting that the A.I.D.S. virus (Acquired Immune Deficiency Syndrome) might kill crucial immune system cells by inducing them to undergo self-destruction, according to Professor Nancy Ruddle from Yale University School of Medicine. During a recent science seminar, Ruddle explained that the A.I.D.S. virus may cause T4 immune cells to produce excessively high levels of a protein called lymphotoxin, which subsequently leads to their death. This hypothesis is being considered as a potential avenue for developing methods to delay the progression of the disease. Ruddle clarified, however, that the theory linking virus-induced lymphotoxin to immune system damage is yet to be conclusively proven. As of now, A.I.D.S. has impacted 18,576 individuals in the United States, resulting in 9,865 fatalities. The virus is known to target T4 cells, essential for fighting infections, thereby crippling the body’s immune responses. The professor pointed out that while T cells usually produce lymphotoxin to combat germs, the A.I.D.S. virus may cause T4 cells to generate it in excess without any targets to act upon. This imbalance may lead to the death of the cell that produces lymphotoxin or nearby T cells. Her experimental observations indicated that infected human T4 cells, when cultured, produce abnormal amounts of a substance likely to be lymphotoxin, which ultimately results in their death. Nevertheless, she noted that this substance has not yet been definitively identified as lymphotoxin. Additional research is being conducted to seek more evidence regarding the presence of lymphotoxin in the blood of individuals diagnosed with A.I.D.S. or a less severe condition known as A.I.D.S.-related complex. Experts in the field, including Mr Frank Rauscher from the Cancer Society and Dr Samuel Broder from the National Cancer Institute, have expressed interest in this hypothesis but also stressed the necessity for further investigation before drawing any solid conclusions. If Ruddle's theory proves to be valid, it could lead to therapeutic strategies focused on inhibiting lymphotoxin production or its effects. Such treatments might be able to manage A.I.D.S. in patients whose immune systems remain functional, although they would not eliminate the virus itself, leaving the possibility open for antiviral medications to perform their role concurrently. Scientists continue to search for effective drugs aimed at eradicating the A.I.D.S. virus altogether.

The text on this page is created, in the most part, using Generative AI and so may contain errors or omissions. It is supplied to you without guarantee or warranty of correctness. If you find an error or would like to make a content suggestion please get in contact

The text on this page is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand